Your browser doesn't support javascript.
Favorable outcome after COVID-19 infection in a multiple sclerosis patient initiated on ocrelizumab during the pandemic.
Ghajarzadeh, Mahsa; Mirmosayyeb, Omid; Barzegar, Mahdi; Nehzat, Nasim; Vaheb, Saeed; Shaygannejad, Vahid; Maghzi, Amir-Hadi.
  • Ghajarzadeh M; Universal council of epidemiology (UCE), universal scientific education and research network (USERN), Tehran University of medical sciences, Tehran, Iran.
  • Mirmosayyeb O; Universal council of epidemiology (UCE), universal scientific education and research network (USERN), Tehran University of medical sciences, Tehran, Iran; Department of Neurology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran; Isfahan Neurosciences Research Center, Isfaha
  • Barzegar M; Department of Neurology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran; Isfahan Neurosciences Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
  • Nehzat N; Universal council of epidemiology (UCE), universal scientific education and research network (USERN), Tehran University of medical sciences, Tehran, Iran; Isfahan Neurosciences Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
  • Vaheb S; Isfahan Neurosciences Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
  • Shaygannejad V; Department of Neurology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran; Isfahan Neurosciences Research Center, Isfahan University of Medical Sciences, Isfahan, Iran. Electronic address: shaygannejad@med.mui.ac.ir.
  • Maghzi AH; Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Mult Scler Relat Disord ; 43: 102222, 2020 08.
Article in English | MEDLINE | ID: covidwho-343145

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Multiple Sclerosis, Relapsing-Remitting / Antibodies, Monoclonal, Humanized / Immunologic Factors Type of study: Case report / Observational study / Prognostic study Topics: Long Covid Limits: Adult / Female / Humans Country/Region as subject: Asia Language: English Journal: Mult Scler Relat Disord Year: 2020 Document Type: Article Affiliation country: J.msard.2020.102222

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Multiple Sclerosis, Relapsing-Remitting / Antibodies, Monoclonal, Humanized / Immunologic Factors Type of study: Case report / Observational study / Prognostic study Topics: Long Covid Limits: Adult / Female / Humans Country/Region as subject: Asia Language: English Journal: Mult Scler Relat Disord Year: 2020 Document Type: Article Affiliation country: J.msard.2020.102222